Micro Imaging Technology - HOT!?

Bin gestern auf diesen Stock aufmerksam geworden - mit über 100 Mio. trades in den USA ist hier eindeutig was im Gange und die Aktie wird seit Tagen in allen möglichen Foren diskutiert u.a. im IHUB - gestern lange Zeit auf Platz 1 bei den Breakout-Boards - Grund dafür gibts auch:

------

Micro Imaging Technology and EPIC Corporation Announce a Significant Equity Alliance

(26.07.2011)

Quelle: http://ih.advfn.com/p.php?pid=nmona&article=48570323

------

Was meint Ihr zu dem Teil? Zock wert?!

Mehr Infos zum Unternehmen: http://www.micro-imaging.com/ 

 

 

Mit nur etwas mehr als 101 Mio im float und den gestrigen Umsätzen, sollte hier doch eigentlich was zu holen sein! :)

 

 

 

SHARE STRUCTURE AS OF LAST 10-Q

 

A/S 500 Mill
Outstanding Shares: 213,791,418
Total Float: 101,620,622 
Insiders on roughly 50% of the float

       

 

 

über dem gestrigen schlusskurs und das ask steht bei 0,004 - in amerika wird auch um diese uhrzeit schon/noch diskutiert!

http://investorshub.advfn.com/boards/board.aspx?board_id=13754

 

ask steigt, bid fällt - wird versucht zu drücken... die meisten meinen, dass ein einstieg unter 0,004 kaum mehr möglich sein wird... bid steht allerdings aktuell auf 0,0024 ... ask bei 0,0046 !

bin gespannt! :)

 

 kurz vor börsenschluss wurden 16 Mio aktien gekauft, die als unterstützung bei 0,0030 dienen und auf mehr hoffen lassen! :)

aktuell: bid 0,0033 / ask 0,0040

ich will meinungen! :) und wenn ihr meint, dass das teil mist ist, will ich das hören - geht ja schließlich auch um mein geld! ;)

 

scheinen gleich mal zu fallen, geht so weiter, wie es gestern aufgehört hat - große umsätze

bid bei 0,0039

21 % plus

 

ask steht gleich mal bei 0,0044

wer auch immer mir da sternchen gibt, soll die lieber dem thread geben ;)

 

EPIC Corporation (PINKSHEETS: EPOR) (the  "Company"), announced that it has entered into a significant long-term  equity alliance with Micro Imaging Technology, Inc. Under the terms of  the signed Memorandum of Understanding, EPIC has committed to purchasing  a substantial equity position in MIT and as a healthcare products and  services company, it will receive the benefits of MIT's revolutionary  technology.

   

"EPIC is fortunate to become a part of Micro Imaging Technology," said  Ronald Tucker, CEO of EPIC. "We believe that Micro Imaging is  undervalued. The Company's balance sheet fails to reflect the value of  the commercialized device for identifying bacteria and the 20 or more  libraries that can be used to identify other bacterium, including MRSA."

 

ABOUT MICRO IDENTIFICATION TECHNOLOGIES:

MIT is a California-based public company that has developed and  patented a Rapid Microbial Identification System that revolutionizes the  pathogenic bacteria diagnostic process. The System identifies bacteria  in minutes and at a significant per test cost savings when compared to  any conventional methods. It does not rely on chemical or biological  agents, conventional processing, fluorescent tags, gas chromatography or  DNA analysis. The process requires only clean water and a sample of the  unknown bacteria.

 

MIT previously completed an extensive evaluation by the AOAC RI  Institute which included rigorous independent testing and thorough  reviews by its expert examiners, including the U.S. Department of  Agriculture.

 

MIT has also demonstrated the ability to detect and identify, within  several minutes, the microbes Escherichia coli, Listeria, Salmonella,  Staphylococcus aureus, and other pathogenic bacteria. The System can  currently identify 23 species of bacteria and its capabilities are  easily expanded. The identification process has been verified by North  American Science Associates, Inc. (NAMSA), an independent and  internationally recognized microbiological testing laboratory. See www.micro-imaging.com.

 

About EPIC

Our business plan is to enter into agreements with companies like  Micro Imaging who are developing technology to provide people with  better healthcare. The essence of these agreements is to provide the  companies with funding for regulatory approval, if necessary, product  commercialization, product procurement, marketing and distribution. See www.epiccor.com.

 

 

 

CONTACT:

Ronald Tucker

 

CEO

 

Email:

Email Contact

Telephone: (760) 771-0036

 

Micro Imaging Technology, Inc. (OTCBB: MMTC)  (OTCQB: MMTC) announced that it has entered into a significant long-term  equity alliance with EPIC Corporation (OTC: EPOR). Under the terms of  the signed Memorandum of Understanding, EPIC has committed to purchasing  a substantial equity position in MIT and, as a health care products  supplier, will receive the benefits of MIT's revolutionary technology.

 

MIT has developed and patented a Microbial Identification System that  revolutionizes the pathogenic bacteria identification process and can  annually save thousands of lives and tens of millions in health care  costs. The MIT 1000 System is believed to be the fastest and most  inexpensive bacterial identification system available; identifying  bacterial strains in less than five minutes, at a cost of less than 10  cents per test and extremely easy to operate. The MIT 1000 System has  been certified by the AOAC Research Institute (AOAC RI) as a test method  for Listeria, one of the three pathogens that are responsible for most  of the worldwide food contaminations. The Company is in the process of  preparing the MIT 1000 System for further certifications for the  identification of both Salmonella and E. coli later this year. This will  give the MIT 1000 System the certified ability to identify all "three  of the major infectious pathogens" within five minutes and with a single  test.

   

"EPIC is fortunate to become a part of Micro Imaging Technology," said  Ronald Tucker, CEO of EPIC. "We believe that Micro Imaging is  undervalued. The Company's balance sheet fails to reflect the value of  the commercialized device for identifying bacteria and the 20 or more  libraries that can be used to identify other bacterium, including MRSA."

 

"EPIC's business plan is to enter into agreements with companies like  Micro Imaging, who are developing technologies to provide people with  better healthcare. The essence of these agreements is to provide the  companies with funding for regulatory approval, product  commercialization, product procurement, marketing and distribution,"  stated Mr. Tucker.

 

Replying, Michael Brennan, MIT's Chairman, said, "The agreement with  EPIC will provide us with needed funding now that we have entered our  production stage and provides a partner that is very familiar with the  healthcare industry. This will enable MIT to approach other markets in  healthcare in addition to the $5 billion food safety segment."

 

ABOUT MICRO IDENTIFICATION TECHNOLOGIES:

 

MIT is a California-based public company that has developed and patented  a Rapid Microbial Identification System that revolutionizes the  pathogenic bacteria diagnostic process and can annually save thousands  of lives and tens of millions of health care costs. The System  identifies bacteria in minutes, not days, and at a significant per test  cost savings when compared to any conventional method. It does not rely  on chemical or biological agents, conventional processing, fluorescent  tags, gas chromatography or DNA analysis. The process is totally GREEN  requiring only clean water and a sample of the unknown  bacteria. Revenues for all rapid testing methods exceed $5 billion  annually -- with food safety accounting for over $3.5 billion, which is  expected to surpass $4.7 billion by 2015 according to BCC Research. In  addition, the recently passed "New" U.S. Food Safety Bill is expected to  further accelerate the current CAGR growth rate of 6.6%.

 

MIT previously completed an extensive evaluation by the AOAC RI  Institute which included rigorous independent testing and thorough  reviews by its expert examiners, including the U.S. Department of  Agriculture. The AOAC RI Report is available from the Company. www.aoac.org

 

MIT has also demonstrated the ability to detect and identify, within  several minutes, the microbes Escherichia coli, Listeria, Salmonella,  Staphylococcus aureus, and other pathogenic bacteria. MIT recently  performed over 300 tests for the identification of these contaminants  and scored 95% accuracy. The System can currently identify 23 species of  bacteria and its capabilities are easily expanded. The identification  process has been verified by North American Science Associates, Inc.  (NAMSA), an independent and internationally recognized microbiological  testing laboratory. The NAMSA Test Report is available from the Company  and, in MIT's opinion, demonstrates the accuracy, speed and cost  effectiveness of the System over conventional processes. www.namsa.com

 

This release contains statements that are forward-looking in nature.  Statements that are predictive in nature, that depend upon or refer to  future events or conditions or that include words such as "expects,"  "anticipates," "intends," "plans," "believes," "estimates," and similar  expressions are forward-looking statements. These statements are made  based upon information available to the Company as of the date of this  release, and we assume no obligation to update any such forward-looking  statements. These statements are not guarantees of future performance  and actual results could differ materially from our current  expectations. Factors that could cause or contribute to such differences  include, but are not limited to dependence on suppliers; short product  life cycles and reductions in unit selling prices; delays in development  or shipment of new products; lack of market acceptance of our new  products or services; inability to continue to develop competitive new  products and services on a timely basis; introduction of new products or services  by major competitors; our ability to attract and retain qualified  employees; inability to expand our operations to support increased  growth; and declining economic conditions, including a recession. These  and other factors and risks associated with our business are discussed  from time to time within our filings with the Securities and Exchange  Commission. www.sec.gov, Referencing MMTC.

 

CONTACT:

Michael Brennan

Chairman

Email: Email Contact

Web Site: www.micro-imaging.com

Telephone: (805) 557-0614

 

bid steigt.. wenn die 0,004 nachhaltig gebrochen sind, ists ganz dünn... sollte dann eigentlich nur noch eine richtung kennen... wenn man die news genauer bedenkt und versteht, ist das ne riesensache die da grad passiert oder meine englischkenntnisse lassen zu wünschen übrig!

 

MPID	Bid Price	Size	Date/Time
VERT	0.0038	25000	12:11
NITE	0.0036	2070000	12:48
ETMM	0.0036	38439	12:03
AUTO	0.0032	300000	12:50
UBSS	0.0011	500000	12:42
VFIN	0.001	5000	11/09
HDSN	0.0008	5000	07/19
CSTI	0.0001	5000	06/30
PERT	0.0001	5000	10:37

     

http://www.otcmarkets.com/stock/MMTC/quote

 

 

irre

 

trades

 

Aug. 8, 2011, 9:01 a.m. EDT  
 
EPIC and Micro Imaging Technology Enter Strategic Alliance and EPIC Declares Stock Dividend
 
 AUSTIN, TX, Aug 08, 2011 (MARKETWIRE via COMTEX) -- EPIC Corporation  (pinksheets:EPOR) (the "Company") announced an equity investment in  Micro Imaging Technology,  Inc. ("MIT"), the execution of a master distribution agreement for  MIT's products, the formation of EPIC Healthcare, LLC, and a stock  dividend in its common stock.  
 
"Our equity investment in MIT  is in a convertible promissory note," said Ronald Tucker, CEO of EPIC.  "The note, after six months from the issuance date, is convertible into  MIT's common stock based on its fair market value as of the time of  conversion."  
 
The Company has formed EPIC Healthcare, Ltd., a  single member limited liability company, and is to be the Master  Distribution company for the MIT products.  
 
"Under the  distribution agreement, we are preparing a program to license MIT's  hardware and software libraries for detecting over 20 different types of  bacterium," said Mr. Tucker. "We believe that within the next year we  will sell close to 30 licenses generating approximately $900,000 in one  time license fees. In addition, we will receive a monthly maintenance  fee, and a fee per test."  
 
The Company's Board of Directors  has declared a stock dividend payable in its common stock to  shareholders of record as of December 30, 2011. The shareholders will  receive 1 new share for each share owned (1:1).  
 
MIT is a  California-based public company that has developed and patented a Rapid  Microbial Identification System that revolutionizes the pathogenic  bacteria diagnostic process. This system can detect and identify, within  minutes, the microbes Escherichia coli, Listeria, Salmonella,  Staphylococcus aureus, and other pathogenic bacteria. The process has  been verified by North American Science Associates, Inc. (NAMSA), and  has been through an extensive evaluation by the AOAC RI Institute.  
 
 EPIC's business plan is to enter into agreements with companies like  MIT who are developing technology to provide people with better  healthcare. See www.epiccor.com .  
 
 
 
         
        CONTACT:
        Ronald Tucker
        CEO
        Email: Email Contact
        Telephone: (760) 771-0036
 

 

http://topics.nytimes.com/top/news/business/...hnology-inc/index.html

 

schaut euch das teil doch mal an, die news, die story dahinter.

das ist es was MMTC macht:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65995315

und das ist es was sie u.a. anbieten:
"The  MIT 1000 features 35 photo detectors that surround the sample vial and  collect light scattering intensities that are generated when a cell  intersects the laser beam. The scattering values collected by the  detectors are statistically analyzed by MIT's proprietary software that  contains an extensive database of values for each bacteria seen by the  photo detectors. Identification occurs when 10-50 organisms are  analyzed, and typically takes less than 10 minutes."

 

es ist bereits die rede davon, dass der MIT 1000 in sachen bakterien-forschung/analyse/etc neue maßstäbe setzt und revolutionär ist... ich denke, dass nach den 100 % von gestern, heute erstmal gewinnmitnahmen kommen werden und es durchaus sein kann, dass man hier nochmal billig einsteigen kann. nach den letzten 2 wochen und dem enorm gestiegenen interesse, denk ich, dass hier nach oben hin jede menge platz ist!

 

auf 0,0115

 

 

in der ersten halben stunde! nach leichtem minus gehts wieder aufwärts, hier steckt wirklich dynamit drinnen - alles möglich bei dem volumen - vielleicht fallen sogar die 0,015 oder 0,02 - mal sehen :)

 

aufm ihub ist die hölle los!

 

optimaler zeipunkt zum einsteigen

 

nmM!!!

 

noch warten oder kaufen ? von 1000€ wieviel investieren ?  

nur so viel, dass es nicht weh tut! :)

 

Bitte überprüfen Sie die Stückzahl und wählen Sie den gewünschten Handelsplatz aus.

ich kann die gar nicht ordern über sbroker :-/

okisch voidindexxx  

pinksheets nicht handeln? muss bei manchen brokern extra angefragt werden... auch bei den meisten banken, meine tradet viele pennys nur via telefonbanking